Pulmonary hypertension in type 1 Gaucher's disease: genetic and epigenetic determinants of phenotype and response to therapy (Q44163800)

30 November 2017

Pulmonary hypertension in type 1 Gaucher's disease: genetic and epigenetic determinants of phenotype and response to therapy (English)

1 reference

30 November 2017

1 reference

pulmonary hypertension

1 reference

Pramod K Mistry

1

1 reference

30 November 2017

Sandra Sirrs

2

1 reference

30 November 2017

Alicia Chan

3

1 reference

30 November 2017

Mark R Pritzker

4

1 reference

30 November 2017

Thomas P Duffy

5

1 reference

30 November 2017

Marie E Grace

6

1 reference

30 November 2017

David P Meeker

7

1 reference

30 November 2017

Martin E Goldman

8

1 reference

30 November 2017

1 September 2002

1 reference

Molecular Genetics and Metabolism

30 November 2017

1 reference

30 November 2017

77

1 reference

30 November 2017

91-98

1 reference

30 November 2017

1-2

1 reference

Gaucher's disease: past, present and future

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900122-1

7 January 2021

Plasma and metabolic abnormalities in Gaucher's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900122-1

7 January 2021

Elevation of Serum Angiotensin-Converting Enzyme in Gaucher's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900122-1

7 January 2021

Gaucher's disease of the lung causing severe pulmonary hypertension with associated acute recurrent pericarditis

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900122-1

7 January 2021

Severe pulmonary involvement in adult Gaucher's disease. Report of three cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900122-1

7 January 2021

Unusual cardiac, renal and pulmonary involvement in Gaucher's disease. Intersitial glucocerebroside accumulation, pulmonary hypertension and fatal bone marrow embolization

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900122-1

7 January 2021

Pulmonary hypertension developing after alglucerase therapy in two patients with type 1 Gaucher disease complicated by the hepatopulmonary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900122-1

7 January 2021

Gaucher cells in pulmonary-capillary blood in association with pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900122-1

7 January 2021

Pulmonary pathology in Gaucher's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900122-1

7 January 2021

Genotype/phenotype correlations in Gaucher's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900122-1

7 January 2021

Discrepancies between genotype and phenotype in hematology: an important frontier

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900122-1

7 January 2021

Pulmonary hypertension in two patients with type I Gaucher disease while on alglucerase therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900122-1

7 January 2021

Pulmonary Hypertension after Splenectomy?

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900122-1

7 January 2021

Genetic and molecular mechanisms of pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900122-1

7 January 2021

Enzyme replacement therapy for Gaucher disease: critical investigations beyond demonstration of clinical efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900122-1

7 January 2021

Lessons learned from the development of enzyme therapy for Gaucher disease

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900122-1

7 January 2021

Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900122-1

7 January 2021

Continuous intravenous epoprostenol therapy for pulmonary hypertension in Gaucher's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900122-1

7 January 2021

Echocardiographic assessment of pulmonary hypertension in Gaucher's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900122-1

7 January 2021

A practical approach to diagnosis and management of Gaucher's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900122-1

7 January 2021

Prenatal genetic carrier testing using triple disease screening

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900122-1

7 January 2021

An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900122-1

7 January 2021

Failure of resting echocardiography and cardiac catheterization to identify pulmonary hypertension in two patients with type I Gaucher disease

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900122-1

7 January 2021

Clinical insights into the pathogenesis of primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900122-1

7 January 2021

Lipid mediator dysregulation in primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900122-1

7 January 2021

ACE genotype and risk of high altitude pulmonary hypertension in Kyrghyz highlanders.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900122-1

7 January 2021

Therapeutic delivery of proteins to macrophages: implications for treatment of Gaucher's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900122-1

7 January 2021

10.1016/S1096-7192(02)00122-1

Identifiers

DOI

1 reference

30 November 2017

1 reference